BioAnalyte, Inc.

In 2008, BioAnalyte introduced MSRedux, a framework for the rapid creation of custom tools for report generation. In the second half of 2008, BioAnalyte produce five MSRedux products: three for large pharmaceutical companies, one for the US FDA and one for Indiana University. In previous years, BioAnalyte introduce a "consumable" software license model that transforms high end software from a capital expense into an operating expense. BioAnalyte's sustainable competitive advantage is its ability to elucidate raw data formats and integrate state-of-the-art engineering processes in a multi-vendor, cross platform setting. BioAnalyte supports raw data formats from a number of major instrument vendors, including Waters Corporation (NYSE:WAT) and Thermo Fisher Corporation (NYSE:TMO), Agilent (NYSE:A), Life Technologies (NASDAQ:LIFE, formerly Applied BioSystems) and Bruker (NASDAQ:BRKR).